Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03194893
Brief Title: A Roll Over Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer

First Submitted : June 20, 2017
First Submitted that Met QC Criteria : June 20, 2017
First Posted : June 21, 2017

Last Update Submitted that Met QC Criteria : December 5, 2019
Last Update Posted : December 9, 2019